Item 5. Market for Registrant’s Common Equity
ITEM 5 - MARKET FOR
REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our Common Stock is currently traded on the Nasdaq
Capital Market under the symbol “FTFT.” Prior to December 31, 2018, our stock traded on the Nasdaq Global Market, and before
that, on the NYSE Amex.
As of March 16, 2026, there were 5,240,544 shares of our Common Stock
issued and outstanding, and the Company had approximately 34 record holders of Common Stock. The number of holders of record does not
include the number of persons whose stock is in nominee or “street name” accounts through brokers.
Dividend Policy
We have never declared or paid any cash dividends
on our Common Stock. The payment of dividends is at the discretion of the Board and is contingent on our revenues and earnings, capital
requirements, financial condition and the ability of our operating subsidiaries to obtain governmental approval to send funds out of
the PRC. We currently intend to retain all earnings, if any, for use in business operations. Accordingly, we do not anticipate declaring
any dividends in the near future.
The PRC’s national currency, the RMB or
yuan, is not a freely-convertible currency. Please refer to the Risk Factors “ Governmental control of currency conversion may
affect the value of shareholder investment ,” and “ PRC regulations relating to offshore investment activities by PRC
residents may limit our PRC subsidiary’s ability to increase its registered capital or distribute profits to us or otherwise expose
us or our PRC resident beneficial owners to liability and penalties under PRC law ”.
Recent Sales of Unregistered Securities and Use of Proceeds
The Company did not make any sales of unregistered
securities during the fiscal year ended December 31, 2025 that were not previously disclosed in a quarterly report on Form 10-Q or a
current report on Form 8-K.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table sets forth information as
of December 31, 2025, with respect to our equity compensation plans previously approved by stockholders and equity compensation plans
not previously approved by stockholders.
Equity Compensation Plan Information
Plan Category
Number of
securities
to be
issued
upon
exercise of
outstanding
options,
warrants
and rights
Weighted
average
exercise
price of
outstanding
options,
warrants
and rights
Number of
securities
remaining
available for
future
issuance
under equity
compensation
plans
(excluding
securities
reflected in
column (a))
(a)
(b)
(c)
Equity compensation plans approved by stockholders (1)
-
$ -
5,000,000
Equity compensation plans not approved by stockholders
-
$ -
-
Total
-
$ -
5,000,000
(1)
At the Company’s 2025 Annual Meeting of Stockholders, stockholders approved an equity incentive plan authorizing the issuance of
up to 5,000,000 shares of the Company’s common stock. The amounts presented in the table above reflect the number of shares authorized
under the plan as of December 31, 2025. On January 20, 2026, the Company effected a 1-for-4 reverse stock split, and the number of shares
authorized under the plan was proportionately adjusted to approximately 1,250,000 shares.
As of December 31, 2025, no awards had been granted under the plan, and no shares were subject to outstanding options, warrants, or other
rights. The Company has not filed a registration statement on Form S-8 with respect to the shares reserved under the plan.
41
ITEM 6 - [RESERVED]
Not Applicable.